Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-27

FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin's generic eslicarbazepine acetate (original application) for use in treating partial-onset seizures in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)